Director of Access and Policy Research at Johnson & Johnson, Ulrich Neumann, MBA, MSc, MA episode artwork

EPISODE · Aug 13, 2025 · 37 MIN

Director of Access and Policy Research at Johnson & Johnson, Ulrich Neumann, MBA, MSc, MA

from Perspectives by the Leerink Center for Pharmacoeconomics · host The Leerink Center for Pharmacoeconomics

Melanie Whittington, PhD, Head of the Leerink Center for Pharmacoeconomics, interviews Ulrich Neumann, MBA, MSc, MA, Director of Access and Policy Research at Johnson & Johnson, to discuss the motivation behind the recent launch of the J&J Center for U.S. Healthcare Policy Research, the interconnectedness and importance of the various players within the biopharmaceutical R&D ecosystem, and the private capital that is required to develop new drugs. Resources mentioned in this episode: https://policyresearch.jnj.com https://jnjinnovation.com/home https://www.nature.com/articles/d41573-024-00131-2 https://www.ispor.org/docs/default-source/intl2024/j-j-access-policy-research---ispor-2024---pharma-r-d-ecosystem-investment137860-pdf.pdf?sfvrsn=d28181d4_0 https://www.tandfonline.com/doi/full/10.1080/13696998.2024.2405407

Melanie Whittington, PhD, Head of the Leerink Center for Pharmacoeconomics, interviews Ulrich Neumann, MBA, MSc, MA, Director of Access and Policy Research at Johnson & Johnson, to discuss the motivation behind the recent launch of the J&J Center for U.S. Healthcare Policy Research, the interconnectedness and importance of the various players within the biopharmaceutical R&D ecosystem, and the private capital that is required to develop new drugs. Resources mentioned in this episode: https://policyresearch.jnj.com https://jnjinnovation.com/home https://www.nature.com/articles/d41573-024-00131-2 https://www.ispor.org/docs/default-source/intl2024/j-j-access-policy-research---ispor-2024---pharma-r-d-ecosystem-investment137860-pdf.pdf?sfvrsn=d28181d4_0 https://www.tandfonline.com/doi/full/10.1080/13696998.2024.2405407

NOW PLAYING

Director of Access and Policy Research at Johnson & Johnson, Ulrich Neumann, MBA, MSc, MA

0:00 37:04

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Perspectives by the Leerink Center for Pharmacoeconomics?

This episode is 37 minutes long.

When was this Perspectives by the Leerink Center for Pharmacoeconomics episode published?

This episode was published on August 13, 2025.

What is this episode about?

Melanie Whittington, PhD, Head of the Leerink Center for Pharmacoeconomics, interviews Ulrich Neumann, MBA, MSc, MA, Director of Access and Policy Research at Johnson & Johnson, to discuss the motivation behind the recent launch of the J&J Center...

Can I download this Perspectives by the Leerink Center for Pharmacoeconomics episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!